2014Practical Journal of Cardiac Cerebral Pneumal and Vascular DiseaseRequires access

Effect of Valsartan Combined with Amlodipine on Elderly Patients with Hypertension Combined with Early Kidney Damage

Wang Bi

Open publisher page 0 citations

Abstract

Objective To observe the effect of Valsartan combined with Amlodipine on elderly patients with hypertension combined with early kidney damage. Methods 98 patients with hypertension combined with early kidney damage admitted to our hospital from October 2010 to April 2013 were divided into Valsartan combined with Amlodipine group( A group,35 cases),Valsartan group( B group,32 cases),Amlodipine group( C group,31 cases). A group was given Valsartan combined with Amlodipine,B group was given Valsartan,C group was given Amlodipine,all treated for 8 weeks. The blood pressure,BP compliance rate,liver function,renal function,blood electrolytes,mALB,adverse reactions among 3 groups before and after 4,8 weeks of treatment were compared. Results After 4 and 8 weeks of treatment,the blood pressure drop and BP compliance rate were higher than those of groups B and C( P 0. 05). The blood pressure drop and BP compliance rate between two groups showed no significant differences( P 0. 05). Before and after treatment,The ALT,Cr,serum k+among 3 groups showed no significant differences( P 0. 05). Before treatment,the level of mALB among 3 group showed no significant differences( P 0. 05). After 4 and 8 weeks of treatment,the level of mALB in A group was lower than that of groups B and C( P 0. 05). Conclusion Valsartan combined with Amlodipine in treating hypertensive combined with early kidney damage can effectively reduce blood pressure and mALB,improve early kidney damage,and have a higher safety.

About this research paper

What this paper is about

Objective To observe the effect of Valsartan combined with Amlodipine on elderly patients with hypertension combined with early kidney damage. Methods 98 patients with hypertension combined with early kidney damage admitted to our hospital from October 2010 to April 2013 were divided into Valsartan combined with Amlodipine group( A group,35 cases),Valsartan group( B group,32 cases),Amlodipine group( C group,31 cases). A group was given Valsartan combined with Amlodipine,B group was given Valsartan,C group was given Amlodipine,all treated for 8 weeks. The blood pressure,BP compliance rate,liver function,renal function,blood electrolytes,mALB,adverse reactions among 3 groups before and after 4,8 weeks of treatment were compared. Results After 4 and 8 weeks of treatment,the blood pressure drop and BP compliance rate were higher than those of groups B and C( P 0. 05). The blood pressure drop and BP compliance rate between two groups showed no significant differences( P 0. 05). Before and after treatment,The ALT,Cr,serum k+among 3 groups showed no significant differences( P 0. 05). Before treatment,the level of mALB among 3 group showed no significant differences( P 0. 05). After 4 and 8 weeks of treatment,the level of mALB in A group was lower than that of groups B and C( P 0. 05). Conclusion Valsartan combined with Amlodipine in treating hypertensive combined with early kidney damage can effectively reduce blood pressure and mALB,improve early kidney damage,and have a higher safety.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the effect of Valsartan combined with Amlodipine on elderly patients with hypertension combined with early kidney damage. Methods 98 patients with hypertension combined with early kidney damage admitted to our hospital from October 2010 to April 2013 were divided into Valsartan combined with Amlodipine group( A group,35 cases),Valsartan group( B group,32 cases),Amlodipine group( C group,31 cases). A group was given Valsartan combined with Amlodipine,B group was given Valsartan,C group was given Amlodipine,all treated for 8 weeks. The blood pressure,BP compliance rate,liver function,renal function,blood electrolytes,mALB,adverse reactions among 3 groups before and after 4,8 weeks of treatment were compared. Results After 4 and 8 weeks of treatment,the blood pressure drop and BP compliance rate were higher than those of groups B and C( P 0. 05). The blood pressure drop and BP compliance rate between two groups showed no significant differences( P 0. 05). Before and after treatment,The ALT,Cr,serum k+among 3 groups showed no significant differences( P 0. 05). Before treatment,the level of mALB among 3 group showed no significant differences( P 0. 05). After 4 and 8 weeks of treatment,the level of mALB in A group was lower than that of groups B and C( P 0. 05). Conclusion Valsartan combined with Amlodipine in treating hypertensive combined with early kidney damage can effectively reduce blood pressure and mALB,improve early kidney damage,and have a higher safety.

Key concepts: Amlodipine, Valsartan, Medicine, Blood pressure, Renal function, Urology, Group B, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of Valsartan Combined with Amlodipine on Elderly Patients with Hypertension Combined with Early Kidney Damage — Research Paper | ScholarLens